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ABSTRACT 
 
INTRODUCTION: Late-stage cervical cancer diagnosis is an important contributing 
factor to the cervical cancer mortality rate. Screening for cervical cancer is a vital tool in 
reducing the number of late-stage cases, preventing incident cases and reducing 
mortality. Access to care is often a significant barrier to receiving these services. Women 
who have no usual source of care report significantly lower percentages of Pap tests than 
women who have a usual source. South Carolina ranks 13th in the US in cervical cancer 
incidence and 7th in cervical cancer mortality. South Carolina also struggles with a 
primary care physician shortage, ranking 39th in primary care physician density. This 
study aimed (1) To determine the demographic and geographic differences between early 
and late stage cases as well as the distribution of primary care physicians in South 
Carolina (2) To assess the relationship between primary care physician density and the 
risk of late-stage cervical cancer diagnosis. METHODS: Multivariate logistic regression 
models were used to assess the association of primary care physician density to late stage 
cervical cancer diagnosis. Both the main outcome and exposure were mapped. 
RESULTS: Out of 1,992 cervical cancer cases from 2000-2010 44.78% were diagnosed 
late-stage. Census tracts with greater than 0 primary care physicians per 100,000 persons 
had significantly lower odds of late-stage diagnosis than census tracts with 0 primary care 
physicians per 100,000 persons. African-American women, cases diagnosed after 2003, 
and older women all had significantly higher odds of late stage diagnosis.
 iv
 CONCLUSION: Areas with low primary care physician density and high late stage 
diagnosis should be a focus of in cervical cancer screening interventions. 
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CHAPTER I. 
 
INTRODUCTION 
 
1.1 Statement of the problem 
 
Cervical cancer was the most common female cancer in the United States 40 years 
ago.1 Due to widespread use of the Papanicolaou (Pap) test, the incidence rate of cervical 
cancer dropped from 17.2 to 8.0 per 100,000 persons from 1973 to 1999. The mortality 
rate fell accordingly from 6.2 to 2.9 per 100,000.2 However for 2014, there will be an 
estimated 12,360 incident cases of cervical cancer and an estimated 4,020 deaths.3 The 
Healthy People 2020 initiative has set goals to reduce the mortality rate of cervical cancer 
by 10 percent from the baseline of 2.4 (per 100,000 persons) in 2007 to a target of 2.2 by 
2020. It also aims to reduce the incident rate of invasive cervical cancer by 10 percent 
from 7.9 cases (per 100,000) to 7.1 cases.4 
Human Papillomavirus (HPV) has been demonstrated to be a necessary cause of 
cervical cancer and HPV strains 16 and 18 make up approximately 70% of all cervical 
cancers.5 The preinvasive lesions that result from persistent oncogenic HPV infections 
are typically asymptomatic and only discovered by a Pap test. If the lesions are left 
untreated, the lesions can extend from the surface cervical epithelium through the full 
thickness epithelium and eventually through the basement membrane to become invasive 
cervical cancer.6 
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The U.S. Preventive Services Task Force (USPSTF) recommends that women aged 
21 to 65 get a Pap test once every three years.7 Data from the 2010 National Health 
Interview Survey (NHIS) have shown that among women who have not had a 
hysterectomy, 83% had a Pap test within the past three years.8 This percent is much lower 
among women who have no usual source of care. Only 64.9% of these women had a Pap 
test within the past three years. A similar percentage was reported for women who are 
uninsured (63.8%), making access to care an important barrier to cervical cancer 
screening.9 In a case-control study, women who had not received a Pap test had a 
significant 2.7 relative risk increase of invasive cervical cancer as compared to women 
who had received a Pap test. Following the guidelines for Pap tests is key in the 
prevention of cervical cancer. 
Cervical cancer is categorized into stages when it is diagnosed: localized, regional 
and distant.  The American Joint Committee on Cancer  (AJCC) also defines stages 
numerically. These stages 0-4 are based on the TMN system or the extent of the tumor, 
whether the tumor as spread to the lymph nodes and whether it has spread to other sites.10 
The AJCC stages align with localized, regional and distant categorization except AJCC 
includes in situ cases as stage 0. In situ cases refer to cases where the cancer cells are 
only located on the surface of the cervix and have not invaded any deeper cervical 
tissues.10 Localized refers to an invasive malignant neoplasm confined entirely to the 
cervix with no lymph node involvement. Regional is a malignant neoplasm that has 
extended beyond the limits of the cervix directly into surrounding organs or tissues or it 
involves regional lymph nodes by way of the lymphatic system or it has both regional 
extension and the involvement of regional lymph nodes. A distant classification requires 
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a malignant neoplasm that has spread to parts of the body remote from the primary tumor 
either by direct extension or by discontinuous metastasis to distant organs, tissues, or via 
the lymphatic system to distant lymph nodes.11 The distribution of stage diagnosis for 
cervical cancer cases in the U.S. from 2003-2009 is as follows: 47% localized, 36% 
regional, 12% distant, and 4% unknown or unstaged.11  
The absence of Pap tests is one of the most commonly attributed risk factors for 
invasive cervical cancer.12 An established barrier for cervical cancer screening is access 
to care.13 Lack of services or lack of physicians greatly hampers a woman’s ability to 
receive proper screening, diagnosis, and treatment for cervical cancer as recommended.13 
Physicians are often unevenly distributed leading to disparities in rural and low-income 
areas.14 
The United States is currently experiencing primary care physician shortage 
problems. The Health Resources and Services Administration (HRSA) recognizes 5,900 
areas as Primary Care Health Professional Shortage Areas (HPSA). This designation is 
for populations that have one (or less) primary care physician per 3,500 people.15 This 
translates to approximately 29 primary care physicians per 100,000 persons. The shortage 
is exacerbated by the unequal distribution of primary care physicians in the United States. 
While there are approximately 80 primary care physicians per 100,000 people in the US, 
the averages are much different when broken down into urban and rural settings. Urban 
areas have 84 primary care physicians per 100,000, whereas rural areas have only 68 
primary care physicians per 100,000.14 This leaves many people without readily available 
care and can be influential in determining whether or not receive preventive medicine 
like a Pap test. 
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1.2 Significance 
Early detection of cervical cancer is crucial in the reduction of cervical cancer 
mortality. Late-stage diagnosis of cervical cancer (distant) has a five-year survival rate of 
approximately 12%. Regional stage diagnosis has a five-year survival rate around 57%.16 
Conversely, an early diagnosis of cervical cancer (localized) has a five-year survival rate 
of approximately 90%.17 Also contributing to cervical cancer outcomes is socioeconomic 
status. Having a lower socioeconomic status (SES) is associated with higher rates of late-
stage diagnosis for cervical cancer as well as lower survival. Low SES has such a 
powerful impact on cervical cancer mortality that even after late-stage diagnosis is 
controlled for in statistical analysis, those living in high SES census tracts have a 30% 
greater 5-year survival rate than those living in low SES census tracts.18  
Cervical cancer’s burden on the population is grossly disproportionate. Over sixty 
percent of the cases in the United States are in populations of underserved and under-
screened women.9 Living in a medically underserved area (MUA) is also a significant 
predictor of late-stage diagnosis.19 As of October 2012, South Carolina has 189 areas 
listed as Primary Care HPSAs.15 Not having adequate access to care puts these women at 
a significant health disadvantage.  
South Carolina has some of the highest incidence and mortality rates for cervical 
cancer in the country at 8.0 incident cases and 2.3 deaths per 100,000.20 It also is ranked 
13th highest in the nation for percentage of its population living in rural areas.21 Making 
sure the large rural population in South Carolina has adequate access to health care is an 
important step in reducing the incidence and mortality of cervical cancer for the state.  
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1.3 Specific Aims 
 Late-stage diagnosis of cervical cancer has such drastically different survival rates 
than an early diagnosis that it is imperative to understand the risk factors contributing to 
the different outcomes. The lack of availability of health care has been shown to have a 
negative impact on stage of diagnosis for cancer, including cervical, in other states.22–24 
There has not been any prior exploration of the association between primary care 
physician density and late-stage diagnosis in South Carolina for cervical cancer. This 
thesis aims to determine: 
1. The demographic and geographic differences between early and late stage 
cervical cancer diagnosis and the distribution of primary care physicians in South 
Carolina. 
2. If there is an association between primary care physician density and the risk of 
late-stage diagnosis for cervical cancer in South Carolina.  
Hypothesis: Greater primary care physician density will be associated with lower 
odds of late-stage cervical cancer diagnosis, adjusting for SES and other known 
covariates. 
 Finding an association between primary care physician density and late stage 
cervical cancer diagnosis will have an impact on health care policy and cancer 
screening interventions. This research has broad reaching implications and finding an 
effect will influence how future funding is spent to help equalize access to care and 
how best to target those most at risk for late stage cervical cancer. Screening 
interventions are most effective when they are able to reach those who need them 
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most. By identifying risk factors for late stage diagnosis, we will be able to apply 
screening programs more effectively.  
 
 7
CHAPTER II. 
 
LITERATURE REVIEW 
 
 
2.1 Cervical Cancer in South Carolina 
 South Carolina was ranked 14th in the United States for incident cases of cervical 
cancer with an age-adjusted rate of 8.0 per 100,000 and 7th for mortality with an age-
adjusted rate of 2.8 per 100,000 people for 2010.20 In 2009, there were an estimated 170 
incident cases and 60 deaths of cervical cancer in South Carolina.25 HPV is a necessary, 
but not sufficient, cause of cervical cancer.5 Risk factors for cervical cancer include 
tobacco use, parity, oral contraceptive use, previous sexually transmitted infection, and 
socioeconomic status.18,26–28 
 Racial disparities in stage of diagnosis and survival of cervical cancer have been 
documented.29,30 African-American women had an incidence rate of 11.5 per 100,000 
people compared to 7.5 per 100,000 people for European-American women in South 
Carolina from 2002-2006. The mortality rate for African-American women was also 
higher than European Americans in South Carolina for this same period at 4.9 per 
100,000 compared to 1.9 per 100,000.25 
Several counties in South Carolina have extremely high incidence and mortality 
rates. Both Orangeburg and Kershaw counties have cervical cancer incidence rates 
greater than 12.0 cases per 100,000 and mortality rates greater than 3.0 deaths per 100,00
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 (Figure 1, Figure 2). Sumter, Darlington, Florence, and Greenwood counties also 
have similar mortality rates, with the highest in Darlington of 5.0 cervical cancer deaths 
per 100,000 persons.31 This is 78.6% greater than South Carolina mortality rate and 117% 
greater than the United States mortality rate for cervical cancer.32 Other counties with 
very high incidence rates for 2000-2009 were Jasper, Bamberg, Chesterfield, Marlboro, 
Dillon, and Chester counties. Jasper County had a cervical cancer incidence rate of 17.7 
cases per 100,000 persons; this is 121% greater than the South Carolina incidence rate 
and 136% greater than the national incidence rate.31,32  
2.2 Human Papillomavirus (HPV) 
 The transition from HPV to cervical cancer has four steps: HPV acquisition, acute 
HPV infection, persistent HPV infection leading to precancerous changes, and invasive 
cervical cancer. These precancerous changes are called cervical intraepithelial neoplasia 
(CIN).33 As this is a slow process, screening for HPV and/or cervical lesions is a primary 
prevention tool for cervical cancer. The U.S. Preventive Services Task Force 
recommends that women from age 21 to 65 receive a Papanicolaou (Pap) test once every 
three years.33 In 2010, 73.2% of women in the United States, who have not had a 
hysterectomy, reported having a Pap test in the last three years.34 South Carolina had a 
slightly higher percentage that same year, with 83.0% of women reporting having had a 
Pap test in the last three years.8 
 While there are many different types of HPV, 70% of oncogenic infections are 
caused by strains 16 and 18.35 In a cohort study on the University of South Carolina 
campus measuring HPV persistence, 31.7% of the baseline population tested positive for 
HPV and of these infections 58.4% were identified as high risk (HPV 16, 66, 51, 52, and 
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18). HPV 16 accounted for 17.6% of all infections seen at enrollment.36 In Dahlström et 
al, the risk of HPV 16 seropositive women to develop invasive cervical cancer was more 
than twice as high as the risk for seronegative women (OR =2.4; 95% CI, 2.0–3.0).28 
 Making sure women are screened on a regular basis is important in reducing the 
number of incident cases of cervical cancer in the United States. It is estimated that over 
50% of women who developed cervical cancer did not have a Pap test in the last three to 
five years.33 Not having access to health care greatly reduces the percentage of women 
who receive a Pap test. Only 64.9% of women who had no usual source of care and 
63.8% of uninsured women had a Pap test in the last three years.7  
  
2.3 Outcome of Interest: Cervical Cancer Stage at Diagnosis 
 Cervical cancer is broken down into stages when it is diagnosed: localized, 
regional and distant. The American Joint Committee on Cancer  (AJCC) also defines 
stages numerically. These stages 0-4 are based on the TMN system or the extent of the 
tumor, whether the tumor as spread to the lymph nodes and whether it has spread to other 
sites.10 The AJCC stages align with localized, regional and distant categorization except 
AJCC includes in situ cases as stage 0. In situ cases refer to cases where the cancer cells 
are only located on the surface of the cervix and have not invaded any deeper cervical 
tissues.10 Localized refers to an invasive malignant neoplasm confined entirely to the 
cervix with no lymph node involvement. Regional is a malignant neoplasm that has 
extended beyond the limits of the cervix directly into surrounding organs or tissues or it 
involves regional lymph nodes by way of the lymphatic system or it has both regional 
extension and the involvement of regional lymph nodes. A distant classification requires 
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a malignant neoplasm that has spread to parts of the body remote from the primary tumor 
either by direct extension or by discontinuous metastasis to distant organs, tissues, or via 
the lymphatic system to distant lymph nodes.11 The distribution of stage diagnosis for 
cervical cancer in the United States for 2003-2009 is as follows: 47% localized, 36% 
regional, 12% distant, and 4% unknown or unstaged.11 In South Carolina, the distribution 
by stage for 2003-2009 was 46.5% localized, 34.7% regional, 9.4% distant, and 9.4% 
unknown.31  
Diagnosing cervical cancer early is central in reducing cervical cancer mortality. 
Late-stage diagnosis of cervical cancer (distant) has a five-year survival rate of 
approximately 12%. Conversely, an early diagnosis of cervical cancer (localized) has a 
five-year survival rate of approximately 90%.17 The overall survival rate for cervical 
cancer from 2004-2010 was 67.9%.16 While the survival and incidence rate has decreased 
significantly over the past 30 years, the percentage of women diagnosed with invasive 
cervical cancer at the localized stage has not changed much, 63% compared to 52% for 
1975 and 2008, respectively.37 This lack of change indicates that while the many cervical 
cancers are diagnosed at an early stage, there is a substantial proportion that progress to 
regional and distant stages prior to diagnosis.37In a national survey from 2004-2006, the 
Center for Disease Control and Prevention (CDC) found 47% of invasive cervical cancers 
were diagnosed late-stage.38 This percentage varied by race/ethnicity with African 
Americans having the largest percentage of late-stage cases (52.8%) and Hispanic women 
with the lowest percentage (45.9%). Hispanic women also had the highest rate of early 
stage diagnosis at 7.5 cases per 100,000 persons. African American women and European 
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American women had relatively similar rates of early stage diagnosis at 5.5 and 5.3 cases 
per 100,000 persons respectively.38   
 
2.4 Primary Exposure: Primary Care Physician Density Introduction 
 
 Primary care physicians play a significant role in a community’s health. An 
increase of one primary care physician per 10,000 population has been associated with an 
average all-cause mortality reduction of 5.3 percent or 49 deaths per 100,000 per year.39 
Unfortunately, the United States has a primary care physician shortage problem. The 
Health Resources and Services Administration (HRSA) have designated 5,900 areas 
across the U.S. as Primary Care HPSAs. This designation is for populations that have one 
(or fewer) primary care physician per 3,500 people, which translates to 29 primary care 
physicians per 100,000 persons.15 The United States also has thousands of Medically 
Underserved Areas (MUAs). Qualification as a MUA requires a service area score 62.0 
or less out of 100 on the Index of Medical Underservice (IMU) where 0 is the completely 
underserved and 100 is the best served. The IMU takes into account the weighted ratio of 
primary medical care physicians per 1,000 population, infant mortality rate, percentage of 
the population with incomes below the poverty level, and the percentage of the 
population age 65 or over.15 
2.5 Primary Care Physicians in South Carolina 
In 2009, the physician-to-population ratio for South Carolina was 382 individuals 
per one physician. This ratio has been steadily increasing from 702 individuals per one 
physician in 1980. The increase seen in South Carolina is reflected in the United States’ 
at large physician-to-population ratio, which increased from 513 individuals per one 
physician in 1980 to 320 individuals per one physician in 2009.40 While South Carolina 
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has been progressively improving on its physician-to-population ratio, the state still holds 
a large number of MUAs.15 South Carolina currently has 46 counties reporting 189 
Primary Care HPSAs and 44 counties reporting 270 Medically Underserved Areas15. In 
2010, South Carolina had a total physician density of 215.8 per 100,000, ranking it 37th in 
the country. The national average physician density was 258.7 per 100,000. For primary 
care physician density, South Carolina ranked even lower at 39th with 77.4 primary care 
physicians per 100,000. The state with the highest primary care physician density was 
Massachusetts with 129.2 per 100,000.41 In comparison, the United States primary care 
physician density was 90.6 per 100,000 in 2010.42 
 
2.6 Primary Care Physicians and Cancer 
The impact primary care physicians have on cancer can be substantial. In a study 
examining the role of primary care physician in cancer, it was found that over 75% of 
physicians surveyed fulfilled at least one of the key cancer care roles. The most common 
role included assessing patient treatment options and whether or not surgery was an 
option.43 Making sure patients are well informed and comfortable with their treatment 
plan has led to lower anxiety and greater cancer patient satisfaction.44 Primary care 
physicians also provide screening tests for and educational information about developing 
cancer. One survey found that 49% of women had a Pap smear performed by their 
primary care physician.45 Women who lived in an area with less than 100 office-based 
primary care physicians per 100,000 women were statistically significantly less likely to 
report having had a Pap test in the past three years (83.5%) as compared to women who 
lived in an area with 500 or more office-based primary care physicians per 100,000 
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women (87.7%).46 At a county-level, it has been found that an increase of one family 
physician per 10,000 persons was associated with a decrease in incidence of 1.5 cases per 
100,000 and a decrease in mortality of 0.65 cases per 100,000 for cervical cancer.23 
Living in a MUA has also been found to be a significant predictor of late-stage cervical 
cancer diagnosis.17  
Primary care physician density has been shown to have an effect on other cancers. 
An increase in the supply of primary care physicians has also been linked to early 
detection for breast cancer. Each tenth percentile increase in the primary care physician 
supply was associated with a 4% increase in the odds of early detection.24 A study 
conducted in Illinois found that poor geographic access to primary care physicians was 
strongly associated with late-stage diagnosis for breast cancer. This finding is made even 
more interesting by the fact that there was no association found for spatial access to 
mammography and late-stage risk suggesting that primary care physicians may play a 
more significant role in preventing late-stage diagnosis.47 Physicians also have an effect 
on cancer survival. An ecological study of women aged 40 years or greater in Florida 
found that as physician density decreased, the survival among women with breast cancer 
did as well.48 
In low physician density populations, a 14% decrease in incident late-stage 
colorectal cancer was found for counties with higher primary care physician density. This 
negative association was found only in non-metropolitan areas, leading the study to 
advise that efforts aimed at increasing physician supply should target low-density 
underserved populations.22 Other urologic cancers, specifically kidney and renal pelvis 
cancers, have demonstrated a negative relationship between mortality and physician 
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density. Cancer mortality increased significantly as physician density decreased for the 
population. This study found a similar relationship for prostate and bladder cancers, 
although it was only suggestive and not statistically significant.49 Primary care physicians 
can have a significant effect on cancer incidence, mortality, and stage of diagnosis. 
Targeting areas that are designated MUAs or HPSAs is an important step in reducing the 
cervical cancer burden in the United States. 
 
2.5.1 Obstetricians and Gynecologists (OB/GYN) and Cervical Cancer 
 OB/GYNs are a frequent source for cervical cancer screening.50–53 In a cross-
sectional study of Texas primary care providers, which included OB/GYNs, 85.6% of 
OB/GYNs surveyed performed more than 25 Pap tests per week. The majority of family 
practice specialists (52.2%) and community internal medicine specialists (71.4%) 
performed Pap tests less than 10 times per week.53 Seeing an OB/GYN has been found to 
be a strong predictor of receiving more screening and vaccinations.54,52 One study 
predicting whether women aged 55 or older in Appalachia had recently received a Pap 
test found a highly significant odds ratio of 8.45 for women who saw an OB/GYN within 
the past year.52 Women who visit either a gynecologist only, or a general physician and a 
gynecologist, are significantly more likely to receive a Pap test than women who visit a 
general physician only.51 Having access to an OB/GYN has shown an effect on whether 
women reported having a Pap test within the past 3 years. Women who live in an area 
with less than 10 office-based OB/GYNs per 100,000 women had a statistically 
significant lower percentage reporting a Pap test performed within the past 3 years 
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(85.6%) as compared as to women who live in an area with 30 or more office-based 
OB/GYNs per 100,000 women (87.5%).46 
2.6 Other Risk Factors 
2.6.1 Race 
 Cervical cancer does not affect all races equally in terms of incidence and 
mortality. In South Carolina, a significant decrease in survival of African American 
woman was found as compared to European American women, even after adjusting for 
disease stage.55 A Florida cohort study found African American women had significantly 
more regional and distance cancer diagnosis and more poorly differentiated tumors 
compared to European American women. The study also found that Hispanic women 
typically were diagnosed with a more advanced stage disease, but had a longer survival 
times.56 This coincides with previous literature that has found 26-30% increased survival 
for Hispanic women compared to non-Hispanic women.57,58 Interestingly, African 
American women have the highest rates of being screened for cervical cancer.30 In South 
Carolina, 90.4% of African American woman and 84.5% of European American women 
had a Pap test within the past three years according to the 2008 Behavioral Risk Factor 
Surveillance Survey (BRFSS).25 
 There are several racial and ethnic differences for cervical cancer incidence rates. 
The CDC released a report examining HPV-associated cervical cancer age-adjusted rates 
for 2004-2008. It found incidence rates of 7.4 cases per 100,000 for Whites, 9.9 incident 
cases per 100,000 for Blacks, 6.5 incident cases per 100,000 for American Indian/Alaska 
Natives, and 7.1 incident cases per 100,000 for Asian/Pacific Islanders. Hispanics had an 
incident rate of 11.3 per 100,000 compared to a 7.4 per 100,000 incident case rate for 
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Non-Hispanics.59 There are also racial-age disparities that continue to persist for older 
African American women (aged > 50 years).60 African American women also have 
significant differences in treatment. After controlling for stage of disease, African 
American women are more likely to receive no treatment or radiation alone compared to 
surgery or combination of therapies than European Americans or Hispanics.30 This may 
contribute to the high rate of mortality for African American women. Asian or Pacific 
Islander women have 68% greater cervical cancer prevalence currently than they have in 
past years. Asian and Pacific Islander is one of the fastest growing minority groups in the 
United States, which contributes to this increase in cases.61 
 
2.6.2 Socioeconomic Status 
 Late-stage diagnosis of cervical cancer has been associated with low-
socioeconomic status (SES).62 Women who live in lower SES census tracts have 
significantly higher rates of cervical cancer incidence and mortality. After controlling for 
stage of disease, women who live in a low SES tract have a 30% lower 5-year survival 
rate than women who live in a high SES tract.18  
In a Florida study with 5,367 women with cervical cancer, patients who lived in 
communities in which less than 15% of the population lived in poverty had significantly 
worse survival outcomes compared with communities in which there was less poverty.56 
Almost 60% of the African American patients in Brookfield et al. lived below 15% 
poverty, compared to 27.6% of European Americans. At every poverty level in the study 
African American women had a shorter median survival time56 Decreased education 
levels has generally led to an increase in cervical cancer mortality for women of all racial 
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and ethnic groups.18 Having a low SES is such a key predictor of high cervical cancer 
incidence and mortality because of the barriers of access to care that a low SES presents. 
This is demonstrated most effectively in a military healthcare environment where 
everyone has as equal access to care. In a review of 1,553 cases of cervical cancer, no 
statistical difference between stage, incidence, mortality, and grade were found at 
diagnosis even after considering the variable races and SES statuses.63  
 
2.6.3 Tobacco 
 Cigarettes contain known carcinogens and women who smoke cigarettes have a 
significantly greater risk of cervical cancer than nonsmokers (RR=3.42, 95% CI, 2.10 to 
5.57). Exposure to second hand smoke has also been evaluated and found to have a risk 
estimate of 2.96 (95% CI, 1.23 to 7.03) for at least 3 hours of exposure per day.27 
Tobacco by-products have been found in the cervical mucus of women who smoke and 
are believed to damage the DNA of cervical cells promoting the development of cancer.64  
European American women who had been diagnosed with cervical cancer were 
significantly more likely to have used tobacco than African American women. Among 
smokers, European American women had significantly longer survival than African 
American women, 47.7 months compared to 29.1 months.56 
 
2.6.4 Insurance 
 Insurance can play an important role in access to care and whether or not a 
woman receives cervical cancer screening or treatment. Women, who are uninsured, have 
Medicaid, or Medicare have significantly higher risk of late-stage diagnosis of cervical 
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cancer than women who are privately insured.65 O’Malley et al. found that late-stage 
diagnosis was 2.8 times higher in women who were uninsured than women who were 
enrolled in Medicaid. Also, women who were only intermittently enrolled in Medicaid 
had 1.3 times lower late-stage diagnosis than those uninsured.66 Another study examining 
Medicaid enrollment found that Medicaid insured approximately one-fourth of the 
women with cervical cancer. Women enrolled in Medicaid after they were diagnosed 
with cervical cancer were most likely to have a late-stage diagnosis as compared to 
women who insured before diagnosis. A statistically increased risk of death was 
associated with women younger than 65 and not enrolled in Medicaid (OR=2.4 95%CI, 
1.49,3.86), which was surprisingly higher than the risk of death for women greater than 
65 and not enrolled in Medicaid (OR=1.24 95% CI, 0.48, 3.19).67 
 
2.6.5 Sexual and Reproductive Risk Factors 
 The age of first intercourse and number of sexual partners have been found to be 
independent risk factors for cervical cancer.26,68 Previous exposure to chlamydia has been 
associated with a strong increased risk for cervical cancer.26,28 It has suggested that the 
effect of a chlamydia infection occurs early in the carcinogenic process. Chlamydia may 
enable HPV persistence. Dahlström et al. found that chlamydia associated with 
seronegative HPV 16, implying chlamydia may increase the risk to contract HPV 16, or 
enable HPV 16 infections to persist.69 The use of oral contraceptives is significantly 
associated with invasive cervical cancer if the contraceptives are used long enough. Oral 
contraceptive use up to four years have not shown any relationship, but use for longer 
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than five years has been associated with a fourfold increase in the risk of invasive 
cervical cancer (95% CI, 2.1 to 5.5).26  
A high parity has been linked to an increased risk of cervical cancer. In a Costa 
Rican study, women with four births had a 3.5 times increased risk compared to women 
who had one or no births. The study found a significant linear relationship for each 
sequential birth.70 Intrauterine device (IUD) use has been found to have a strong and 
consistent inverse relationship with cervical cancer. Women who have previous IUD had 
half the risk of developing cervical cancer in Castellsagué et al. than women who did not 
have a history of IUD use.71 The study hypothesized that the insertion or removal of an 
IUD produces a long lasting immune response or when the device is inserted or removed 
preinvasive cancer lesions are removed. An IUD was not found to prevent HPV, but it 
could alter the progression of HPV to cervical cancer and therefore could be considered a 
protective factor.71 
 
2.6.6 Age 
As cervical cancer is a slow-growing, it is more likely found in older women.72 A 
retrospective study conducted with 1800 patients diagnosed with cervical cancer found 
that the disease is rare for women aged 20-24. There were more women diagnosed at age 
26 (n=257) than the entire age group 20-24 (n=223). However, women who were 
diagnosed between age 20-24 were more likely to have a more advanced cancer and 
therefore, more aggressive treatment.73 Age has been previously associated with an 
increased risk of late-stage diagnosis for cervical cancer.74 Younger women are also more 
likely to receive a Pap smear test on a regular basis as compared to older women. A 
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significantly higher rate of women not up-to-date on their cervical cancer screening 
(32%) was found among women aged 50 to 69 years compared to women aged 30 to 49 
not up-to-date (20.3%) on their screening.75 
 
2.6.7 Urban/Rural Geography 
 Long-term trends between rural and urban areas for cervical cancer persist today. 
From 1969-2007, while the overall mortality rate fell, rural non-metropolitan areas had a 
morality rate that was still significantly higher than urban metropolitan areas.37 This 
difference between rural and urban rates held true for cervical cancer incidence as well. 
Rural women had an incidence rate 15% significantly greater than urban women. The rate 
of late-stage diagnosis for urban and rural women while different did not yield any 
statistical significance. There was a significant difference, however, in the 5-year survival 
rate of localized stage cervical cancer. Non-metropolitan women had a 5-year survival 
rate of 87.8%, significantly lower than the 91.3% rate for metropolitan women from 
2000-2006.37 
 There are also differences in cervical cancer screening for urban and rural areas. 
Rural Non-Hispanic Whites were found to have a slightly lower prevalence of Pap smear 
testing than their urban counterparts. All rural women aged 35-49 also had a significantly 
lower prevalence of testing than their urban counterparts as well.76 
 
  
3.1 Study Design 
  
 A late stage cancer diagnosis framework was adapted from Mobley 
provide justification for this study.
Figure 3.1. Late Stage Cancer Diagnosis Framework
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disability, and personal resources. Other predisposing factors like race, age, and 
educational status are also individual characteristics of interest. These two levels (i.e., 
person and area level factors) may influence whether an individual utilizes cancer-
screening services and in turn, can affect their cancer diagnosis outcome. This study is 
based on the assumptions that the level 1 and 2 characteristics are influential enough that 
their relationship with late-stage diagnosis will be able to be determined even if screening 
utilization is not taken into account.  
This thesis used retrospective data from the South Carolina Central Cancer 
Registry to analyze primary care physician density and other related covariates and their 
relationship with cervical cancer stage at diagnosis. Descriptive statistics were used to 
depict various biological and socioeconomic risk factors for cervical cancer among 
women in South Carolina. ArcGIS was employed to provide visual geographic 
descriptions of the study population and their outcomes. Multivariate logistic regression 
models were run to assess the relationship between primary care physician density and 
late-stage cervical cancer diagnosis. The USC Institutional Review Board (IRB) 
approved this study on August 30, 2013 (Pro00028635).  
3.2. Participants and Setting 
3.2.1 Study Population 
There were 2,188 incident cervical cancer cases identified from 2000-2010 in 
South Carolina. Data was obtained from the South Carolina Central Cancer Registry 
(SCCCR) through approval on April 3, 2014 from the Department of Health and 
Environmental Control IRB board (IRB14-003). The SCCCR is a division of the South 
Carolina Department of Health and Environmental Control and is a part of the North 
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American Association of Cancer Registries (NAACR). It is a population-based registry 
that collects cancer data for the entire state. As cancer is a reportable disease by law, the 
majority of cases are reported to SCCCR electronically by hospitals. Cases could also 
come from pathology labs, cancer treatment centers, and physicians’ offices. The date of 
diagnosis, location, grade, and histology of tumor, as well as any treatment received, and 
vital status, is reported to SCCCR. Information about the patient’s demographics like age, 
gender, race, and contact information are included in the case report. South Carolina 
residents that are diagnosed or treated out of state are still reported to the SCCCR as it 
has a reciprocal relationship with twenty surrounding states.78 All invasive cervical 
cancer cases from 2000-2010 were included in the initial study population. Cases were 
excluded if they were classified as “unstaged”. This led to 196 of the cervical cancer 
cases being excluded, which left 1,992 cases in the dataset. Due to missing age and race 
data, 1,950 cases were included in the multivariate analysis. 
 
 
3.3. Variables 
3.3.1. Outcome: Late-stage cervical cancer diagnosis 
Cervical cancer cases were obtained from SCCCR, excluding any in situ cases, 
and those with a SEER grade of “regional”(n=689) or “distant” (n=203) were classified 
as a late-stage diagnosis. These were compared to early stage diagnosis or a SEER grade 
of “local” (n=1100).   
 
3.3.2. Covariates: Rurality, Race, Age, Poverty, and Cancer Characteristics 
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 Rurality was determined by census tract-level rural-urban commuting area 
(RUCA) codes. Created from US Census data, RUCA codes classify census tracts using 
measures of population density, urbanization, and daily commuting.79 The RUCA 
classifications included in this study were urban and rural. Urban included codes for 
metropolitan areas, micropolitan areas with a primary or secondary flow within an 
urbanized area or urban cluster up to 49,999. Rural included all other areas. Due to the 
large time frame of this study, 2000 and 2010 RUCA codes were used. 2000 codes were 
assigned to cases diagnosed from 2000-2005 and 2010 codes were assigned to cases 
diagnosed from 2005-2010. Race was obtained from SCCCR and classified as White, 
Black, and Other. Age was also obtained from SCCCR as well as the cancer 
characteristics of each case. The cancer characteristics described for the study population 
were primary site, tumor grade, and histology. Poverty was obtained from SCCCR, which 
determines neighborhood census tract poverty level based on the 2000 US Census and the 
American Community Survey on five year basis. Poverty is categorized into <5%, 5-
9.9%, 10-19.9%, ≥20%, and unknown. All cases assigned “unknown” for poverty (n=43) 
were manually determined using US Census American Community Survey estimates 
based on the case diagnosis year.   
 The South Carolina Central Cancer Registry does not collect information on all 
the known potential confounders and effect modifiers for cervical cancer thus leading to 
an incomplete list of potential confounders used in the actual analysis. The variable list of 
potential confounders used in this thesis is as follows: 
• Race: Race was divided into White, Black and Other 
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• Poverty level: Poverty was categorized as <5%, 5-9.9%, 10-14.9% 15-19.9%, 
≥20% by census tract  
• Age: Age was treated as a categorical variable (<30, 30-49, 50-69, 70+ years) 
• Census Tract Rurality: Urban/Rural was divided into urban and rural based on 
RUCA codes (Urban= <4.0, 4.1, 5.1,7.1,8.1, 10.1 Rural=4.0, 4.2, 5.0, 5.2, 6.1, 
7.0- 7.4, 8.0-10.0, 10.2, >10.2) 
SCCCR does not collect or does not have in completion: smoking status, educational 
status, household income, and insurance status. All of which would have liked to been 
included in analysis. 
 
3.3.4. Primary Exposure: Primary Care Physician Density 
 Primary care physician density was calculated at the census tract and county level. 
There are currently 884 census tracts and 46 counties in South Carolina.80 South Carolina 
medical licenses were used to determine primary care physician density by first filtering 
the licenses for only general practice, family practice, internal medicine, and obstetrics 
and gynecology specialties. As the study period encompasses ten years, lists for medical 
licenses were obtained for 2002, 2003, 2004 and 2009.The addresses provided on the 
medical licenses were geocoded and mapped at the census tract and county level using 
ArcGIS. For all addresses that listed a PO Box, the street address was manually searched 
for using the physician’s name on Google. Using these maps, the number of primary care 
physicians in each census tract and county was calculated, divided by the total 
population, and multiplied by 100,000 to determine density. 2000 census population 
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totals and census tract designations were used as SCCCR labels all cancer cases with 
2000 census tract designations.  
Cases diagnosed from 2000-2002 were assigned 2002 density levels, cases in 
2003 were assigned 2003 density levels, cases in 2004-2006 were assigned 2004 density 
levels, and cases in 2007-2010 were assigned 2009 density levels. This was employed to 
help account for any temporality changes in primary care physician density that may have 
occurred from 2000 to 2010.  
Density was categorized into two levels: none-low and moderate-high. For census 
tract primary care physician density per 100,000 the none-low designation=0, moderate-
high=>0. County level primary care physician density per 100,000 for the none-low 
designation= <30, moderate-high =30-70. The county level cutoff was chosen at 30 
physicians per 100,000 as it translated closely to the HSPA designation of 1 physician per 
3,500.  
 
3.4. Analysis 
3.4.1 Geospatial Mapping  
ArcGIS Version 10.1 (ESRI 2011. ArcGIS Desktop: Release 10. Redlands, CA: 
Environmental Systems Research Institute) was used to map the percentage of late-stage 
cervical cancer diagnoses at the county level for South Carolina. Primary care physician 
density was also mapped at the census tract and county levels.  
3.5 Statistical Methods 
 Aim 1 examined differences between early and late stage cervical cancer using 
descriptive statistics including frequency counts and percentages. The variables compared 
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were race, age, year of diagnosis, census tract rurality, poverty level, and primary cancer 
site. A chi-square test was used to assess statistical differences in early and late stage 
diagnosis for the aforementioned variables.  
For Aim 2, we used logistic regression with stage at cervical cancer diagnosis as 
the outcome variable (0 = localized, 1= regional and distant stages). Logistic regression 
measures the relationship between a binary categorical dependent variable and one of 
more independent variables. The first part of the aim assessed the association between 
primary care physician density and late-stage cervical cancer diagnosis at the census tract 
level. The second part of the aim analyzed the association between primary care 
physician density and late-stage cervical cancer diagnosis at the county level. 
Significance was determined at the alpha=0.05 level.  
Bivariate analysis for late-stage cervical cancer diagnosis as the dependent variable and 
primary care physician density was performed initially for both geographic levels of 
density. The next logistic regression model included all personal covariates and the 
primary exposure: race, age, and year of diagnosis as well as primary care physician 
density. The final logistic regression model was comprised of primary care physician 
density, race, age, year of diagnosis, poverty, and census tract rurality. Covariates that 
were not statistically significant at alpha=0.05, but epidemiologically relevant based on 
the literature were still included in the final model (see Equation 1.0 below). Data 
analysis was performed using SAS Version 9.4. (SAS Institute Inc., Cary, NC, USA) 
(Equation 1.0) 
Logit (P(Late Stage Cervical Cancer Diagnosis))= β0 + β1(PCP density) + β2(race) + 
β3(age) + β4 (year of diagnosis) + β5 (census tract rurality) + β6 (poverty) 
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CHAPTER IV. 
Effect of Primary Care Physician Density on Late Stage Cervical Cancer Diagnosis1 
 
 
 
                                                        
1
 Haanschoten, E. Eberth, J. Adams, A. Brandt, H. Moran, R. To be submitted to Cancer 
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INTRODUCTION 
While great strides have been made in reducing cervical cancer incidence and 
mortality in the last 40 years, there are an estimated 12,360 incident cases and 4,020 
deaths from cervical cancer in 2014 alone.3 A crucial step in reducing cervical cancer 
morality is early detection.9,17,57 Cases diagnosed late-stage have a five-year survival rate 
of approximately 12%. Conversely, early diagnosis cases have a five-year survival rate 
around 90%.17 
 For early detection to be possible, women must have access to appropriate care 
and utilize screening regularly. Only 64.9% of women who reported having no usual 
source of care had a Pap test within the past three years, this is much lower than the 
percentage reported for all women, 83%.8 The density of primary care physicians (PCP) 
in one’s geographic area can influence whether or not a women receives a Pap test, with 
women living in areas of higher PCP density reporting statistically higher rates of Pap 
tests than women living in lower areas of PCP density.51 Increasing county level PCP 
density has also been associated with decreases in cervical cancer incidence and 
mortality.23 Other cancers with strong screening programs like breast and colorectal 
cancer have previously shown relationships between PCP density and odds of late-stage 
diagnosis and cancer mortality.22,24,47,48 Little is known however, about the relationship 
between PCP density and late-stage cervical cancer diagnosis at the census tract level. 
Previous literature has found that living in census tract that is classified as a medically 
underserved area (MUA) is a strong predictor of late stage diagnosis, but an entire state 
by tracts has not been examined as a whole.17 Using census tract level PCP density 
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should provide a more accurate representation of an individual’s primary care access, as 
it is a smaller geographic level and more reflective of nearby PCP availability.  
 As South Carolina is 7th in the U.S. for cervical cancer mortality and 39th for PCP 
density, it provided an ideal environment for exploring this relationship20,41. South 
Carolina also ranks 13th in the nation for percentage of it’s population living in a rural 
area.21 Rurality has a large impact on access to care and can be detrimental in obtaining 
cervical cancer screening services.81 South Carolina also has a large percentage of its 
counties reporting MUA and health care professional shortage areas (HPSA). In fact, 
only 2 counties out of 46 in South Carolina do not contain a MUA.15 Eight counties had 
cervical cancer incidence rates 61% greater than the national rate with one county that 
reported an incidence rate 136% higher than the US.31,32 (Figure 1) Another county in 
South Carolina had a mortality rate 117% greater than the US mortality rate for cervical 
cancer.32 (Figure 2)  
 A late stage cancer diagnosis framework was adapted from Mobley et.al to provide 
justification for this study.77 Market supply factors include primary care physician density 
and OB/GYN density influence. Individual enabling or disabling factors include health 
insurance, disability, and personal resources. Other predisposing factors like race, age, 
and educational status are also individual characteristics of interest. These two levels (i.e., 
person and area level factors) may influence whether an individual utilizes cancer-
screening services and in turn, can affect their cancer diagnosis outcome. This study is 
based on the assumptions that the level 1 and 2 characteristics are influential enough that 
their relationship with late-stage diagnosis will be able to be determined even if screening 
utilization is not taken into account.  
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This study was conducted: (1) To describe the demographic and geographic 
differences between early and late stage cervical cancer diagnosis and the distribution of 
primary care physicians in South Carolina and (2) To determine if there is an association 
between PCP density and the risk of late stage diagnosis for cervical cancer in South 
Carolina at the census tract and county level. This study hypothesized that decreased 
primary care physician density will lead to increased odds of late-stage cervical cancer 
diagnosis. 
 
METHODS 
Data 
Cervical cancer cases, excluding in situ cases, from 2000-2010 were retrieved 
from the South Carolina Central Cancer Registry (SCCCR), South Carolina’s gold-rated 
statewide cancer registry, to assess the risk of late-stage diagnosis.78 Information included 
in the case files along with specific cancer characteristics was race, age, year of 
diagnosis, and census tract poverty. Cases were linked by census tract to rural-urban 
commuting area (RUCA) codes, which classifies tracts using measures of population 
density, urbanization, and daily commuting.79 As the study period spanned 10 years, 2000 
and 2010 RUCA codes were used, with cases from 2000-05 assigned 2000 codes and 
cases from 2006-2010 assigned 2010 codes. 2000 census tract designations were used 
throughout the study period. 
 The primary outcome of interest, late stage diagnosis, was defined using 
Surveillance, Epidemiology and End Results (SEER) categories. Late stage diagnosis 
included “regional” and “distant” cases as compared to early stage diagnosis, which 
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included “localized” cases. Stage was available for 1,992 cases (91.22%) of cases. Un-
staged cases were excluded from analysis (n=192). The final sample consisted of all 
1,992 women with known stage diagnosed with cervical cancer between 2000-2010 in 
SC. Due to missing age and race data, only 1,950 cases were included in the multivariate 
analysis.  
 Data for primary care physician density came from the South Carolina Medical 
Licensing Board.82 Lists of all active medical licenses for 2002, 2003, 2004 and 2009 
were obtained and then filtered for general practice, family practice, internal medicine, 
and obstetrics and gynecology specialties. Obstetricians and gynecologists (OB/GYNs) 
were included as primary care physicians due to the significant role they play in 
providing Pap tests.51,53 To account for temporal changes in the supply of primary care 
physicians, cases diagnosed from 2000-2002 were assigned 2002 density levels, cases in 
2003 were assigned 2003 density levels, cases in 2004-2006 were assigned 2004 density 
levels, and cases in 2007-2010 were assigned 2009 density levels. The addresses 
provided on the medical licenses were geocoded and mapped at the census tract and 
county level using ArcGIS Version 10.1 (ESRI 2011. ArcGIS Desktop: Release 10. 
Redlands, CA: Environmental Systems Research Institute) For all addresses that listed a 
P.O. Box, the street address was manually determined using an Internet search and the 
provider’s name. Density was calculated by dividing the total number of primary care 
physicians in each census tract and county by the respective 2000 and 2010 census 
population totals multiplied by 100,000. Data Analysis The percentages of late-stage 
cervical cancer cases were mapped using ArcGIS Version 10.1 (ESRI 2011. ArcGIS 
Desktop: Release 10. Redlands, CA: Environmental Systems Research Institute) at the 
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county level. PCP density per 100,000 persons was also mapped at the census tract and 
county levels.  
 Differences between early and late stage cervical cancer cases were identified 
using descriptive statistics and Pearson’s chi-square test with a 0.05 alpha level. The 
variables compared included race/ethnicity, age, year of diagnosis, urban/rural, poverty 
level, and primary cancer site.  
 The relationship between PCP density and the odds of late-stage diagnosis was 
examined using multivariate logistic regression. Three models were run for both the 
census tract and county level with late-stage diagnosis as the dependent variable. The first 
model consisted of only the bivariate relationship with PCP density. The second model 
included the primary exposure and all individual level covariates: race, age, and year of 
diagnosis as well as PCP density. The third model contained all of the variables from the 
second model plus covariates for poverty and urban/rural at the census tract level. 
Variables that were statistically insignificant, but epidemiologically relevant based on 
previous literature were retained in the final model. As the incidence of late stage 
diagnosis was greater than 10% and year of diagnosis was known, odds ratios were 
corrected to relative risks as a more appropriate interpretation of the magnitude of the 
association.83  
 As all cases living in the same census tract received the same poverty measure, 
there was concern that a multilevel model was more appropriate for analysis due to the 
hierarchical nature of the data. After further investigation, it was determined that both 
methods yielded very similar results and multivariate logistic regression was suitable for 
analysis.  
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SAS Version 9.4 (SAS Institute Inc., Cary, NC, USA) was used for all statistical analysis, 
and ArcGIS Version 10.1 was used for geocoding and mapping purposes. Approval from 
the South Carolina IRB board was obtain August 30, 2013. 
 
 
RESULTS 
 
 
Of the 1,992 cervical cancer cases included in the descriptive analysis, 44.78% 
(n=892) were diagnosed late-stage. Table 1 shows the study demographics by stage of 
diagnosis. A greater percentage of African-American women made up the late-stage 
diagnosis cases (39.34%), compared to the percentage of African-American women that 
composed the early-stage cases (31.83%). However, the opposite was found for Whites. 
There were a higher percentage of cases among early-stage diagnosis (66.70%) than the 
percentage of cases among late-stage diagnosis (59.86%). This difference was 
statistically significant (p=<.0001). The median age of the study population was 48 years 
and there were statistically significant differences for late stage diagnosis (p=<.0001). 
Cases diagnosed early-stage were slightly younger at 44 years while late-stage cases were 
slightly older at 53 years.  The highest percentage of cases diagnosed for both early and 
late-stage occurred among women aged 30-49 years old (53.82% and 42.04%, 
respectively). Women aged 50-69 made up a larger percentage of the late-stage cases 
(39.57%) than their percentage of the early-stage cases (28.00%). 2000-2003 had the 
lowest percentage of late-stage diagnosis cases and 2004-2007 had the highest.  There 
were no statistically significant differences in late stage diagnosis noted between urban 
and rural areas (p=0.8645). 
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Mapping cervical cancer cases was not possible for census tracts, as only 6 tracts 
(out of 864 in SC) had greater than 10 cases over the time period. SCCCR suppresses 
tracts whose frequencies are less than 10. As expected, PCP density was highest in 
metropolitan areas and lowest in rural areas of the state (Figure 3, Figure 4). 426 of South 
Carolina’s 864 (48.19%) census tracts had a PCP density of 0 per 100,000 persons. Five 
(10.87%) of the South Carolina’s counties had less than 50 primary care physicians per 
100,000 persons. Figure 5 shows the percentage of late-stage cases at the county level. 20 
out of 46 (43.48%) counties had greater than 42% of the cervical cancer cases diagnosed 
as late-stage.  
The results of the logistic regression models run are displayed in Table 2. Women 
living in census tracts with a primary care physician density greater than 0 per 100,000 
were significantly less likely to be diagnosed late-stage compared to women who lived in 
tracts with a PCP density of 0 per 100,000. This was true for all three logistic regression 
models run. Similar results were seen at the county level where counties with greater than 
30 PCPs per 100,000 were compared to those with less, but they were not statistically 
significant (Table 2). African Americans had significantly higher odds of being 
diagnosed late-stage than whites at both the census tract and county level. For both 
geographic levels, increasing age led to increased risk ratios for late-stage diagnosis. In 
the full model, cervical cancer cases diagnosed from 2008-2010 had a significant 
adjusted RR=1.547 (95% CI: 1.244, 1.611) for late-stage diagnosis as compared to cases 
from 2000-2003. Cases living in rural areas were slightly more likely to be diagnosed 
late-stage, but this was not found to be statistically significant (adjusted RR=1.007 
95%CI: 0.952,1.055). The only proxy variable for socioeconomic status, census tract 
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poverty, was significant in bivariate analysis for increased odds of late-stage diagnosis 
for women living in tracts with greater than 10% poverty compared to those in less than 
5% poverty. Once included in a multivariate model, the increased odds were no longer 
significant. 
DISCUSSION 
This is the first investigation into the impact of census tract primary care 
physician density on late-stage cervical cancer diagnosis in South Carolina and any other 
state as a whole. As South Carolina is one of the nation’s leaders in cervical cancer 
mortality, identifying areas that can improve cervical cancer survival is vital. South 
Carolina also has a large percentage of counties with MUAs, HPSAs and overall low 
primary care physician density, making it an ideal environment to study this relationship. 
Our analysis found that increased primary care physician density significantly decreased 
the risk of late-stage cervical cancer diagnosis when considered at the census tract level. 
While this association was not significant at the county level, the relative risk ratios were 
very similar. This suggests that access to care; specifically a primary care physician or an 
OB/GYN plays an impactful role in reducing late-stage cervical cancer diagnosis in 
South Carolina.  Examining PCP density at the census tract allowed a more nuanced 
investigation into this relationship than other studies that only looked at the county 
level.17,23  
Counties with highest percentage of late stage cases were often the counties with 
the lowest PCP density as was the case for Lee and Saluda counties. Lee County had 
27.5% of its population below the poverty level from 2008-2012 and African Americans 
make up 63.9% of its citizens.84 In Saluda County, however, 18.1% of its population was 
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below poverty level from 2008-2012 and is 26.3% African American, but Saluda County 
is more rural than Lee County at 43.9 persons per square mile in 2010 compared to 46.9 
persons.84 Mapping revealed that counties with highest percentages of late stage cases 
were frequently surrounded by counties with the lowest percentages of late stage cases. 
Further comparison found that they also differ by PCP density. While there are other 
factors that likely contributed to the difference in stage diagnosis, PCP density is 
certainly worth full consideration.  
Interestingly, counties with the highest percentage of late-stage cervical cancer 
diagnosis were not always the counties with highest mortality rates. Orangeburg, 
Florence, and Greenwood have some of the highest mortality rates in South Carolina, but 
all reported only approximately 42-53% of their cervical cancer cases as late stage. 
(Figure 2, Figure 5) Conversely, Laurens and Dorchester counties had some of the 
highest percentages of late-stage diagnosis in South Carolina, but reported low morality 
rates for 2000-2009.31 Laurens County mortality rate had to be suppressed because it was 
so low. These differences may be an issue of access to care. Laurens and Dorchester are 
both adjacent to counties that have hospitals with gynecologic oncologists (i.e., 
Greenville, Spartanburg, and Charleston). Women in Orangeburg and Greenwood would 
have to travel much further to receive care from an equivocal source. This disparity in 
access to cervical cancer treatment may explain why the counties with the highest 
mortality rates were also not the counties with highest percentage of late-stage diagnosis. 
There are currently only 5 counties in South Carolina that have gynecologic oncology 
specialists (Greenville, Richland, Florence, Charleston, Spartanburg). This leaves 
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thousands of women in South Carolina without easily accessible cervical cancer care if 
they were to need it. 
A disproportionate number of African American women were affected by cervical 
cancer in this study population. African American women compose approximately 29% 
of the South Carolina female population, but make up 34.74% of all the cervical cancer 
cases from 2000-2010.84 African American women were also more likely to be diagnosed 
late-stage, which falls in line with previous literature.9,29,58 Interestingly, women 
diagnosed with cervical cancer after 2003 have a higher odds of late-stage diagnosis 
compared to those diagnosed from 2000-2003 with 2008-2010 cases having the highest 
risk. This may be a reflection of the decline in percentage of women that have had a 
regular Pap test, which has been seen in South Carolina and the United States as a 
whole.85 Nationally, 67% of women aged 22-30 reported a Pap test in the last 3 years in 
2010, down from 78.1% in 2000.34 There was also an increase in this age group of 
women who reported never having a Pap test. Nine percent of women aged 22-30 in 2010 
as compared to 6.6% in 2000.34 One reason for this decline may be the changes in 
screening guidelines over this time period. The American Cancer Society (ACS), U.S. 
Preventive Services Task Force (USPSTF), and the American College of Obstetricians 
and Gynecologists (ACOG) all changed their cervical cancer screening guidelines, some 
multiple times, creating a confusing environment for women and their physicians.  
This study was limited by a lack of socioeconomic and lifestyle factors included 
in analysis, especially smoking. Smoking is an influential risk factor for late-stage 
cervical cancer diagnosis26,27,86 . It could not be included in the analysis due to lack of 
information from SCCCR. The only proxy variable for socioeconomic status, census tract 
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poverty, was significant in bivariate analysis, but insignificant after adjustment for other 
covariates. Not knowing the insurance status of the study population was another 
limitation as it can play a substantial role in access to care and cervical cancer 
outcomes2,56,65. 
This research will be an important baseline and foundation when it comes to 
examining the effect of the Affordable Care Act on cervical cancer outcomes. The 
Affordable Care Act ensures that insurance companies provide reimbursement for 
women’s preventive services including cervical cancer screening.87 As demonstrated in 
the late stage cancer framework, monitoring the utilization of screening is important for 
the reduction of late stage diagnosis. As more women sign up for insurance through state 
and federal health exchanges, and more women have cervical cancer screening covered 
through their insurance plans, it will be important to further examine the relationship 
between primary care physician density, the utilization of screening services, and late-
stage cervical cancer diagnosis.  
Areas with low primary care physician densities and high late stage cervical 
cancer diagnosis should also be targets for clinical and policy interventions. These areas 
should be identified as potential sites for federally qualified health centers (FQHC) if 
they haven’t been already. FQHCs can provide a safety net to communities that are 
otherwise lacking access to care.88 Training on cervical cancer screening guidelines 
should be encouraged in all clinical practices as it has been through a recent upheaval and 
is often confusing. 
In conclusion, we found that increasing the density of primary care physicians 
was associated with decreased risk of late stage cervical cancer diagnosis, especially at 
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the census tract level. This study suggests the significant impact that primary care 
physicians and OB/GYNs can have in reducing the cervical cancer burden. Having access 
to care and being able to utilize screening services are important commodities in reducing 
late-stage diagnosis, which in turn can reduce the overall cervical cancer mortality 
burden. Screening interventions should target areas with low PCP density to maximize 
their effectiveness.  
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Table 4.1. Study Demographics by Stage 
 Early (n=1100) 
55.22% 
Late (n=892) 
44.78% P-value 
 
%(n) %(n)  
Race   <.0001 
White 66.70 (723) 59.86 (528)  
Black 31.83 (345) 39.34 (347)  
Other 1.48 (16) 0.79 (7)  
Age   <.0001 
<30 9.55 (105) 2.13 (19)  
30-49 53.82 (592) 42.04 (375)  
50-69 28.00(308) 39.57(353)  
70+ 8.64 (95) 16.26 (145)  
Year of Dx   <.0001 
2000-2003 44.45 (489) 30.27 (270)  
2004-2007 31.45 (346) 37.00 (330)  
2008-2010 24.09 (265) 32.74 (292)  
Poverty   0.0010 
<5% 9.14 (98) 6.28 (55)  
5-9.9% 20.62 (221) 16.89 (148)  
10-19.9% 40.58 (434) 39.95 (350)  
≥20 29.66 (318) 36.87 (323)  
Urban/Rural    
Urban 78.08 (823) 78.41 (679) 0.8645 
Rural 21.92 (231) 21.29 (187)  
Primary Site 
  
<.0001 
Endocervix 19.42 (214) 12.19 (109)  
Exocervix 1.18 (13) 1.34 (12)  
Overlap lesion cervix 
uteri 1.63 (18) 2.57 (23) 
 
Cervix uteri 77.77 (857) 83.89 (750)  
*Pearson’s chi-square test 
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 Census Tract County 
 
Model 1 Model 2 Model 3 Corrected RR Model 1 Model 2 Model 3 Corrected RR 
Density* 
        
None-Low 
Ref Ref Ref Ref Ref Ref Ref Ref 
Moderate-
High 0.822 (0.686,0.984) 
0.774 
(0.641,0.936) 
0.778 
(0.641,0.945) 
0.854 
(0.748,0.996) 
0.884 
(0.692,1.128) 
0.823 
(0.636,1.063) 
0.843 
(0.651,1.092) 
0.845 
(0.662,1.087) 
Race 
        
White 
 Ref Ref Ref  Ref Ref Ref 
Black 
 
1.292 
(1.060,1.574) 
1.234 
(1.002,1.520) 
1.08 
(1.001,1.159)  
1.283 
(1.053,1.0564) 
1.228 
(0.997,1.512) 
1.081 
(0.999,1.157) 
Other 
 
0.585 
(0.231,1.480) 
0.493 
(0.186,1.313) 
0.708 
(0.363,1.016)  
0.577 
(0.227,1.466) 
0.493 
(0.185,1.313) 
0.708 
(0.362,1.106) 
Age 
        
< 30 
 Ref Ref Ref  Ref Ref Ref 
30-49 
 
3.351 
(1.982,5.665) 
3.513 
(2.050,6.021) 
3.335 
(2.005,5.439)  
3.282 
(1.942,5.546) 
3.435  
(2.006,5.883) 
3.266 
(1.964,5.329) 
50-69 
 
6.101 
(3.581,10.393) 
6.293 
(3.646,10.862) 
5.655 
(3.451,8.976)  
6.005 
(3.527,10.223) 
6.184  
(3.585,10.665) 
5.569 
(3.380,8.844) 
Table 4.2 The Odds of Late Stage Cervical Cancer Diagnosis 
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70+ 
 
8.319 
(4.682,14.781) 
8.539 
(4.737,15.392) 
7.358 
(4.388,11.781)  
8.174 
(4.603,14.513) 
8.382 
(4.653,15.096) 
7.243 
(4.317,11.610) 
Year of Dx 
        
2000-2003 
 Ref Ref Ref  Ref Ref Ref 
2004-2007 
 
1.801 
(1.441,2.251) 
1.748 
(1.391,2.195) 
1.425 
(1.244,1.612)  
1.805 
(1.445,2.255) 
1.769 
(1.412,2.217) 
1.435 
(1.347,1.740) 
2008-2010 
 
2.114 
(1.691,2.674) 
2.209 
(1.391,2.195) 
1.574 
(1.244,1.611)  
2.102 
(1.662,2.658) 
2.016 
(1.585,2.565) 
1.542 
(1.347,1.710) 
Urban/Rural 
        
Urban 
  Ref Ref   Ref Ref 
Rural 
  
1.033 
(0.809,1.318) 
1.007 
(0.952,1.055)   
1.007 
(0.790,1.284) 
1.002 
(0.946,1.050) 
Poverty 
        
< 5% 
  Ref Ref   Ref Ref 
5-9.9% 
  
1.109 
(0.734,1.677) 
1.101 
(0.747,1.609)   
1.144 
(0.758,1.726) 
1.106 
(0.770,1.651) 
10-19.9% 
  
1.250 
(0.848,1.842) 
1.231 
(0.856,1.750)   
1.321 
(0.900,1.939) 
1.295 
(0.906,1.831) 
>=20% 
  
1.384 
(0.809,2.063) 
1.351 
(0.818,1.934)   
1.433 
(0.963,2.132) 
1.395 
(0.965,1.990) 
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Figure 4.1. Cervical Cancer Incidence Rate per 100,000 persons in South Carolina by county, 2000-2009 
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Figure 4.2. Cervical Cancer Mortality Rate per 100,000 in South Carolina by County, 2000-2009 
	
Mortality Rate per 100,000 
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 Figure 4.3. Primary Care Physician Density per 100,000 persons in South Carolina by census tract, 2009 
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 Figure 4.4. Primary Care Physician Density per 100,000 persons in South Carolina by county, 2009 
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Figure 4.5. Percent of Late Stage Cervical Cancer Diagnosis in South Carolina by county, 2000-2010 
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CHAPTER V.  
 
CONCLUSION 
 
Summary of Results 
 In summary, census tracts with a primary care physician density greater than 0 per 
100,000 persons have significant decreased odds of late stage cervical cancer diagnosis 
compared to census tracts with a primary care physician density of 0 per 100,000 persons. 
At the county level, similar decreased odds were also seen but it was not a statistically 
significant relationship. More recent years of diagnosis (2003 and later), older women, 
and African Americans all had significantly increased odds for late stage diagnosis at 
both geographic levels. Rural tracts and increased poverty also had elevated odds ratios 
for late stage diagnosis but were not significant in the multivariate models. Census tract 
poverty, however, significantly increased the odds of late stage diagnosis during bivariate 
analysis. 
 
Significance of Findings 
 To date no other study has analyzed the impact of primary care physician density 
at the census tract level on the risk of late-stage cervical cancer diagnosis. All previous 
studies either examined county level densities or MUA tracts only and not an entire 
state.17,23 This study found a deceased risk for late-stage diagnosis in census tracts and 
counties with “medium-high” PCP density as compared to areas with “none-low” PCP
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 density. The association was statistically significant at the census tract level after 
adjusting for sex, age, year of diagnosis, urban/rural, and tract poverty. The inclusion of 
OB/GYNs as a part of primary care physician density is another unique factor of this 
study. OB/GYNs are highly influential in cervical cancer screening, but have not been 
previously included in PCP density analysis for late-stage cervical cancer diagnosis. 
Their addition is important to capture an accurate and complete picture of providers that 
provide cervical cancer screening.  
 As a state that is consistently ranked among the top of the charts in cervical 
cancer incidence and mortality, South Carolina has significant room for improvement. 
Reducing the number of cases diagnosed late-stage is one way to combat high cervical 
cancer mortality rates. As a state with a high rural population, a large number of HPSAs, 
and MUAs, and a large number of incident cases, South Carolina provides an ideal 
environment for studying the relationship between late-stage cervical cancer diagnosis 
and primary care physician density. South Carolina is also a state that rejected Medicaid 
expansion. An estimated 340,000 additional individuals would qualify for Medicaid if the 
state expanded the program or approximately 8.5% of South Carolina’s total population 
and 40.5% of South Carolina’s population below the poverty line.80,89  
 This research can be used to help focus cervical cancer screening interventions. 
Targeting areas low in PCP density and high in late-stage diagnosis with mobile clinics or 
other resources to increase screening access will hopefully decrease the frequency of late-
stage cervical cancer diagnosis. Identifying the counties and census tracts with low PCP 
density is also important for influencing health policy that aims to reduce access to care 
disparities, especially through a cervical cancer lens. Programs like the Best Chance
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 Network that provides cervical cancer screening to low-income women can use this 
research to narrow in on areas that are most in need of their services.  
 
Further Research 
 Further research should be conducted to assess whether this inverse relationship 
between PCP density and late-stage cervical cancer diagnosis is true across multiple 
states and regions in the United States. Additional analysis should include other 
covariates like smoking, marital status, insurance status, as well as education level or 
household income. Adding these variables to the analysis will help control for 
confounding and provide better indicators for socioeconomic status.  
Further research should also examine the complete relationship in the late-stage 
cancer framework including the intermediary step of cervical cancer screening that was 
not able to be included in this study. This research should examine the relationship 
between primary care physician density, cervical cancer screening utilization, and their 
impacts on late-stage cervical cancer diagnosis. One way to accomplish this might be to 
inspect the effect of the Affordable Care Act on cervical cancer screening rates and how 
that ultimately affects late-stage cervical cancer diagnosis. The Affordable Care Act 
provides free preventive women’s services like cervical cancer screening, which should 
help increase the number of women who do not receive Pap tests within the 
recommended guidelines. Monitoring and screening for cervical cancer is crucial in the 
reduction of late-stage cervical cancer diagnosis. This study provides a backdrop and 
baseline of information of which to build further research on and will be important as a 
reference for further research in late-stage cervical cancer diagnosis
  
51
REFERENCES 
 
1.  Horner, MJ; Ries, LAG; Krapcho M et al. SEER Cancer Statistics Review, 1975-
2006.; 2009. 
2.  Hewitt M, Devesa SS, Breen N. Cervical cancer screening among U.S. women: 
analyses of the 2000 National Health Interview Survey. Prev Med (Baltim). 
2004;39(2):270-8. doi:10.1016/j.ypmed.2004.03.035. 
3.  Siegel R, Naishadham D, Jemal A. Cancer Statistics , 2013. 2013;63(1):11-30. 
doi:10.3322/caac.21166. 
4.  Services UD of H and H. 2020 Topics and Objectives. Heal People. 2013. 
Available at: 
http://healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=5. 
5.  Trottier H, Franco EL. The epidemiology of genital human papillomavirus 
infection. Vaccine. 2006;24 Suppl 1:S1-15. doi:10.1016/j.vaccine.2005.09.054. 
6.  Trottier H, Franco EL. Human papillomavirus and cervical cancer: burden of 
illness and basis for prevention. Am J Manag Care. 2006;12(17 Suppl):S462-72. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/17203990. 
7.  Report M and MW. Cancer Screening - United States, 2010.; 2012:41-5. Available 
at: http://www.ncbi.nlm.nih.gov/pubmed/23282862. 
8.  Prevention C for DC and. Percent of Women Age 18 and Older Who Report 
Having Had a Pap Smear Within the Last Three Years. Behav Risk Factor Surveill 
Syst Surv Data. 2010. Available at: http://kff.org/womens-health-policy/state-
indicator/pap-smear-rate/. 
9.  Scarinci IC, Garcia F a R, Kobetz E, et al. Cervical cancer prevention: new tools 
and old barriers. Cancer. 2010;116(11):2531-42. doi:10.1002/cncr.25065. 
10.  Society AC. Cervical Cancer. 2014. 
11.  Institute NC. Stage of Disease at Diagnosis. SEER. 2003. 
12.  Leyden W a, Manos MM, Geiger AM, et al. Cervical cancer in women with 
comprehensive health care access: attributable factors in the screening process. J 
Natl Cancer Inst. 2005;97(9):675-83. doi:10.1093/jnci/dji115. 
13.  Daley E, Alio A, Anstey EH, Chandler R, Dyer K, Helmy H. Examining barriers 
to cervical cancer screening and treatment in Florida through a socio-ecological 
lens. J Community Health. 2011;36(1):121-31. doi:10.1007/s10900-010-9289-7. 
14.  Petterson, Stephen; Phillips, Robert; Bazemore, Andrew; Koinis G. Unequal 
Distribution of the U.S. Primary Care Workforce.; 2013:2013. 
15.  Administration HR and S. Shortage Designation: Health Professional Shortage 
Areas & Medically Underserved Areas/Populations. 2013. Available at: 
http://www.hrsa.gov/shortage/.
 
16.  SEER. SEER Stat Fact Sheets: Cervix Uteri Cancer. Cancer Stat. 2014. Available 
at: http://seer.cancer.gov/statfacts/html/cervix.html. 
  
52
17.  Barry J, Breen N. The importance of place of residence in predicting late-stage 
diagnosis of breast or cervical cancer. Health Place. 2005;11(1):15-29. 
doi:10.1016/j.healthplace.2003.12.002. 
18.  Singh GK, Miller B a, Hankey BF, Edwards BK. Persistent area socioeconomic 
disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 
1975-2000. Cancer. 2004;101(5):1051-7. doi:10.1002/cncr.20467. 
19.  Lawson, Herschel; Henson, Rosemarie; Bobo, Janet; Kaeser M. Implementing 
Recommendations for the Early Detection of Breast and Cervical Cancer Among 
Low-Income Women.; 2000. 
20.  Prevention C for DC and. United States Cancer Statistics. US Cancer Stat Work 
Gr. 2013. Available at: www.cdc.gov/uscs. 
21.  Board SCB and C. Urban and Rural Populations in South Carolina. South Carolina 
Community Profiles. 
22.  Ananthakrishnan AN, Hoffmann RG, Saeian K. Higher physician density is 
associated with lower incidence of late-stage colorectal cancer. J Gen Intern Med. 
2010;25(11):1164-71. doi:10.1007/s11606-010-1457-z. 
23.  Campbell RJ, Ramirez AM, Perez K, Roetzheim RG. Cervical cancer rates and the 
supply of primary care physicians in Florida. Fam Med. 2003;35(1):60-4. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/12564867. 
24.  Ferrante JM, Gonzalez EC, Pal N, Roetzheim RG. Effects of physician supply on 
early detection of breast cancer. J Am Board Fam Pract. 2000;13(6):408-14. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/11117337. 
25.  Savoy JE, Hurley DM, Brandt HM, Bolick-Aldrich SW, Ehlers ME. Cervical 
cancer in South Carolina: epidemiologic profile. J S C Med Assoc. 
2009;105(7):227-30. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/20108706. 
26.  Castellsagué X, Muñoz N. Chapter 3: Cofactors in human papillomavirus 
carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. J Natl 
Cancer Inst Monogr. 2003;(31):20-8. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12807941. 
27.  Slattery ML, Robison LM, Schuman KL, et al. Cigarette Smoking and Exposure to 
Passive Smoke Are Risk Factors for Cervical Cancer. J Am Med Assoc. 
1989;261(11):1593-1598. 
28.  Arnheim Dahlström L, Andersson K, Luostarinen T, et al. Prospective 
seroepidemiologic study of human papillomavirus and other risk factors in cervical 
cancer. Cancer Epidemiol Biomarkers Prev. 2011;20(12):2541-50. 
doi:10.1158/1055-9965.EPI-11-0761. 
29.  Rauh-Hain JA, Clemmer JT, Bradford LS, et al. Racial disparities in cervical 
cancer survival over time. Cancer. 2013;119(20):3644-52. 
doi:10.1002/cncr.28261. 
30.  Akers AY, Newmann SJ, Smith JS. Factors underlying disparities in cervical 
cancer incidence, screening, and treatment in the United States. Curr Probl 
Cancer. 2007;31(3):157-81. doi:10.1016/j.currproblcancer.2007.01.001.
 
31.  Control SCD of H and E. SCAN Cancer Incidence and Mortality. 2013. Available 
at: http://scangis.dhec.sc.gov/scan/cancer2/home.aspx. 
  
53
32.  Institute D of H and HSC for DC and PNC. United States Cancer Statistics: 1999-
2010 Incidence and Mortality Web-Based Report. Atlanta, GA; 2013. Available at: 
www.cdc.gov/uscs. 
33.  Vesco KK, Whitlock EP, Eder M, Burda BU, Senger CA, Lutz K. Risk factors and 
other epidemiologic considerations for cervical cancer screening: a narrative 
review for the U.S. Preventive Services Task Force. Ann Intern Med. 
2011;155(10):698. doi:10.7326/0003-4819-155-10-201111150-00377. 
34.  Statistics NC for H. Health, United States, 2013.; 2014. 
35.  Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in 
invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. 
Int J Cancer. 2007;121(3):621-632. doi:10.1002/ijc.22527. 
36.  Banister CE, Messersmith AR, Chakraborty H, et al. HPV prevalence at 
enrollment and baseline results from the Carolina Women’s Care Study, a 
longitudinal study of HPV persistence in women of college age. Int J Womens 
Health. 2013;5:379-88. doi:10.2147/IJWH.S45590. 
37.  Singh GK. Rural-urban trends and patterns in cervical cancer mortality, incidence, 
stage, and survival in the United States, 1950-2008. J Community Health. 
2012;37(1):217-23. doi:10.1007/s10900-011-9439-6. 
38.  Henley, SJ; King, JB; German, RR; Richardson LPM. Surveillance of screening-
detected cancers (colon and rectum, breast, and cervix)—United States, 2004–
2006. MMWR Surveill Summ. 2010;59(9):1-25. 
39.  Macinko J, Starfield B, Shi L. Quantifying the health benefits of primary care 
physician supply in the United States. Int J Health Serv. 2007;37(1):111-26. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/17436988. 
40.  Smart D. Physician Characteristics and Distribution in the US 2011.; 2011. 
41.  Colleges A of AM. 2011 State Physician Workforce Data Book.; 2011. 
42.  Center TRG. Primary Care Physician Mapper. Am Acad Fam Physicians. 2012. 
43.  Klabunde CN, Ambs A, Keating NL, et al. The role of primary care physicians in 
cancer care. J Gen Intern Med. 2009;24(9):1029-36. doi:10.1007/s11606-009-
1058-x. 
44.  Hubbard G, Kidd L, Donaghy E. Preferences for involvement in treatment decision 
making of patients with cancer: A review of the literature. Eur J Oncol Nurs. 
2008;12(4):299-318. Available at: 
http://linkinghub.elsevier.com/retrieve/pii/S1462388908000355?showall=true. 
45.  Nicole Lurie, Karen L. Margolis PGM, Pamela J. Mink JSS. Why Do Patients of 
Female Physicians Have Higher Rates of Breast and Cervical Cancer Screening? J 
Gen Intern Med. 1997;12:34-43. 
46.  Coughlin SS, Leadbetter S, Richards T, Sabatino S a. Contextual analysis of breast 
and cervical cancer screening and factors associated with health care access among 
United States women, 2002. Soc Sci Med. 2008;66(2):260-75. 
doi:10.1016/j.socscimed.2007.09.009.
 
47.  Wang F, McLafferty S, Escamilla V, Luo L. Late-Stage Breast Cancer Diagnosis 
and Health Care Access in Illinois. Prof Geogr. 2008;60(1):54-69. 
doi:10.1080/00330120701724087. 
  
54
48.  Fleisher JM, Lou JQ, Farrell M. Relationship between physician supply and breast 
cancer survival: a geographic approach. J Community Health. 2008;33(4):179-82. 
doi:10.1007/s10900-008-9090-z. 
49.  Colli J, Sartor O, Thomas R, Lee BR. Does urological cancer mortality increase 
with low population density of physicians? J Urol. 2011;186(6):2342-6. 
doi:10.1016/j.juro.2011.07.069. 
50.  Perkins RB, Anderson BL, Gorin SS, Schulkin J a. Challenges in cervical cancer 
prevention: a survey of U.S. obstetrician-gynecologists. Am J Prev Med. 
2013;45(2):175-81. doi:10.1016/j.amepre.2013.03.019. 
51.  Lewis BG, Halm EA, Marcus SM. Preventive Services Use Among Women Seen 
by Gynecologists , General Medical Physicians, or Both. Obstet Gynecol. 
2008;111(4):945-952. 
52.  Leach CR, Schoenberg NE. The vicious cycle of inadequate early detection: a 
complementary study on barriers to cervical cancer screening among middle-aged 
and older women. Prev Chronic Dis. 2007;4(4):A95. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2099293&tool=pmcen
trez&rendertype=abstract. 
53.  Holland-Barkis P, Forjuoh SN, Couchman GR, Capen C, Rascoe TG, Reis MD. 
Primary care physicians’ awareness and adherence to cervical cancer screening 
guidelines in Texas. Prev Med (Baltim). 2006;42(2):140-5. 
doi:10.1016/j.ypmed.2005.09.010. 
54.  McCall-Hosenfeld, Jennifer; Weisman, Carol; Camacho, Fabian; Hillemeir, 
Marianne; Chauang C. Multi-Level Analysis of the Determinants of Receipt of 
Clinical Preventive Services Among Reproductive-Age Women. Womens Heal 
Issues. 2012;22(3):e243-e251. doi:10.1016/j.whi.2011.11.005.Multi-Level. 
55.  Adams SA, Fleming A, Brandt HM, et al. Racial Disparities in Cervical Cancer 
Mortality in an African American European American Cohort in South Carolina. J 
South Carolina Med Assoc. 2010;105(7):237-244. 
56.  Brookfield KF, Cheung MC, Lucci J, Fleming LE, Koniaris LG. Disparities in 
survival among women with invasive cervical cancer: a problem of access to care. 
Cancer. 2009;115(1):166-78. doi:10.1002/cncr.24007. 
57.  Eggleston KS, Coker AL, Williams M, Tortolero-Luna G, Martin JB, Tortolero 
SR. Cervical cancer survival by socioeconomic status, race/ethnicity, and place of 
residence in Texas, 1995-2001. J Womens Health (Larchmt). 2006;15(8):941-51. 
doi:10.1089/jwh.2006.15.941. 
58.  Patel DA, Barnholtz-Sloan JS, Patel MK, Malone Jr. JM, Chuba PJ, Schwartz K. A 
population-based study of racial and ethnic differences in survival among women 
with invasive cervical cancer: Analysis of Surveillance, Epidemiology, and End 
Results data. Gynecol Oncol. 2005;97(2):550-558. 
doi:http://dx.doi.org/10.1016/j.ygyno.2005.01.045. 
59.  Prevention C for DC and. Human Papillomavirus-Associated Cancers-United 
States, 2004-2008.; 2012:258-261. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/24135574.
 
  
55
60.  Simard EP, Naishadham D, Saslow D, Jemal A. Age-specific trends in black-white 
disparities in cervical cancer incidence in the United States: 1975-2009. Gynecol 
Oncol. 2012;127(3):611-5. doi:10.1016/j.ygyno.2012.08.021. 
61.  Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez E a, Plaxe SC. Changing 
demographics of cervical cancer in the United States (1973-2008). Gynecol Oncol. 
2012;126(3):330-3. doi:10.1016/j.ygyno.2012.05.035. 
62.  Ave V, Reichman ME, Miller BA, et al. Impact of socioeconomic status on cancer 
incidence and stage at diagnosis: selected findings from the surveillance, 
epidemiology, and end results: National Longitudinal Mortality Study. 
2010;20(4):417-435. doi:10.1007/s10552-008-9256-0.Impact. 
63.  Farley JH, Hines JF, Taylor RR, et al. Equal care ensures equal survival for 
African-American women with cervical carcinoma. Cancer. 2000;91(4):869-73. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/11241257. 
64.  Winklestein J. Smoking and cervical cancer current status: a review. Am J 
Epidemiol. 1990;131(6):945-57. 
65.  Fedewa S a, Cokkinides V, Virgo KS, Bandi P, Saslow D, Ward EM. Association 
of insurance status and age with cervical cancer stage at diagnosis: National 
Cancer Database, 2000-2007. Am J Public Health. 2012;102(9):1782-90. 
doi:10.2105/AJPH.2011.300532. 
66.  O’Malley CD, Shema SJ, Clarke LS, Clarke C a, Perkins CI. Medicaid status and 
stage at diagnosis of cervical cancer. Am J Public Health. 2006;96(12):2179-85. 
doi:10.2105/AJPH.2005.072553. 
67.  Bradley CJ, Given CW, Roberts C. Health care disparities and cervical cancer. Am 
J Public Health. 2004;94(12):2098-103. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1448598&tool=pmcen
trez&rendertype=abstract. 
68.  Louise A. Brinton, Ph.D., Richard F. Hamman, M.D., Dr.P.H., George R. 
Huggins, M.D., Herman F. Lehman, D.D.S., Robert S. Levine, M.D., Katherine 
Mallin, Ph.D., and Joseph F. Fraumeni, Jr. MD. Sexual and Reproductive Risk 
Factors for Invasive Squamous Cell Cervical Cancer. J Natl Cancer Inst. 
1987;79:23-30. 
69.  Stitzenberg KB, Thomas NE, Dalton K, et al. Distance to diagnosing provider as a 
measure of access for patients with melanoma. JAMA dermatology. 
2007;143(8):991-8. doi:10.1001/archderm.143.8.991. 
70.  Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus 
in cervical cancer: the IARC multicentric case-control study. Lancet. 
2002;359(9312):1093-1101. Available at: 
http://linkinghub.elsevier.com/retrieve/pii/S0140673602081515. 
71.  Castellsagué X, Díaz M, Vaccarella S, et al. Intrauterine device use, cervical 
infection with human papillomavirus, and risk of cervical cancer: a pooled analysis 
of 26 epidemiological studies. Lancet Oncol. 2011;12(11):1023-31. 
doi:10.1016/S1470-2045(11)70223-6. 
72.  Kosary CL, Angeles L. Chapter 14 Cancer of the Cervix Uteri. In: ; 2006:111-122.
 
  
56
73.  Castanon a, Leung VMW, Landy R, Lim a WW, Sasieni P. Characteristics and 
screening history of women diagnosed with cervical cancer aged 20-29 years. Br J 
Cancer. 2013;109(1):35-41. doi:10.1038/bjc.2013.322. 
74.  Mandelblatt J, Andrews H, Kerner J, Zauber a, Burnett W. Determinants of late 
stage diagnosis of breast and cervical cancer: the impact of age, race, social class, 
and hospital type. Am J Public Health. 1991;81(5):646-9. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1405079&tool=pmcen
trez&rendertype=abstract. 
75.  Siahpush , M; Singh G. Sociodemographic predictors of pap test receipt, currency 
and knowledge among Australian women. Prev Med (Baltim). 2002;35(4):262-8. 
76.  Doescher MP, Jackson JE. Trends in cervical and breast cancer screening practices 
among women in rural and urban areas of the United States. J Public Health 
Manag Pract. 2009;15(3):200-9. doi:10.1097/PHH.0b013e3181a117da. 
77.  Mobley, Lee; Kuo, Tzy-Mey; Watson, Lisa; Brown G. Geographic Disparities in 
Late-Stage Cancer Diagnosis: Multilevel Factors and Spatial Interactions. Heal 
Place. 2013;18(5):978-990. doi:10.1016/j.healthplace.2012.06.009.Geographic. 
78.  Registry SCCC. About the Registry. 
79.  Agriculture USD of. Rural-Urban Commuting Area Codes. Econmic Res Serv. 
2013. 
80.  Bureau USC. South Carolina 2010 Census - Census Tract Reference Maps. 
Census. 2010. 
81.  Yabroff KR, Lawrence WF, King JC, et al. Geographic disparities in cervical 
cancer mortality: what are the roles of risk factor prevalence, screening, and use of 
recommended treatment? J Rural Health. 2005;21(2):149-57. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/15859052. 
82.  South Carolina Department of Labor L and R. South Carolina Board of Medical 
Examiners. Available at: http://www.llr.state.sc.us/pol/medical/. 
83.  Zhang, J; Yu K. What’s the Relative Risk? A Method of Correcting the Odds Ratio 
in Cohort Studies of Common Outcomes. JAMA. 1998;280:1690-1691. 
84.  Bureau USC. State & County QuickFacts.; 2014. Available at: 
http://quickfacts.census.gov/qfd/states/45.html. 
85.  Prevention C for DC and. Cervical Cancer Screening Rates.; 2010. Available at: 
http://www.cdc.gov/cancer/cervical/statistics/screening.htm. 
86.  Du P, Lemkin A, Kluhsman B, et al. The roles of social domains, behavioral risk, 
health care resources, and chlamydia in spatial clusters of US cervical cancer 
mortality: not all the clusters are the same. Cancer Causes Control. 
2010;21(10):1669-83. doi:10.1007/s10552-010-9596-4. 
87.  Patient Protection and Affordable Care Act. USA; 2010. 
88.  Services D of H and H. Federally Qualified Health Center.; 2013. 
89.  Services C for M. South Carolina Medicaid Moving Forward in 2014. 
Medicaid.gov. 2014. Available at: http://www.medicaid.gov/Medicaid-CHIP-
Program-Information/By-State/south-carolina.html.  
 
